A Practical Photochemical Synthesis of 6-AZA-1, 10-Phenanthroic Anhydride
摘要:
A high yield synthesis of 6-aza-1,10-phenanthroic anhydride has been developed. The key step is a volume-efficient photochemical cyclization of azastilbene 5 to the photochemically stable dihydroazaphenanthrene 9.
A Practical Photochemical Synthesis of 6-AZA-1, 10-Phenanthroic Anhydride
摘要:
A high yield synthesis of 6-aza-1,10-phenanthroic anhydride has been developed. The key step is a volume-efficient photochemical cyclization of azastilbene 5 to the photochemically stable dihydroazaphenanthrene 9.
The synthesis and antitumor evaluation of unsymmetrical bis-imides
作者:Robert J. Cherney、Stephen G. Swartz、Arthur D. Patten、Emeka Akamike、Jung-Hui Sun、Robert F. Kaltenbach、Steven P. Seitz、Carl H. Behrens、Zelleka Getahun、George L. Trainor、Mike Vavala、Mindy R. Kirshenbaum、Lisa M. Papp、Margaret P. Stafford、Philip M. Czerniak、Richard J. Diamond、Ronald J. McRipley、Roni J. Page、Janet L. Gross
DOI:10.1016/s0960-894x(96)00591-4
日期:1997.1
Unsymmetrical bis-imides 1 were synthesized and evaluated as potential antitumor agents. These novel bis-imides were assessed using three criteria: in vitro cytotoxicity (L1210), in vitro DNA binding, and in vivo studies with human tumor xenografts in mice. These studies identified DMP 315 as a potent, water soluble antitumor agent. (C) 1997, Elsevier Science Ltd.
BIS-IMIDE POLYCYCLIC AND HETEROCYCLIC CHROMOPHORES USEFUL AS TUMORICIDALS
申请人:THE DU PONT MERCK PHARMACEUTICAL COMPANY
公开号:EP0705250A1
公开(公告)日:1996-04-10
US5416089A
申请人:——
公开号:US5416089A
公开(公告)日:1995-05-16
US5585382A
申请人:——
公开号:US5585382A
公开(公告)日:1996-12-17
[EN] BIS-IMIDE POLYCYCLIC AND HETEROCYCLIC CHROMOPHORES USEFUL AS TUMORICIDALS<br/>[FR] CHROMOPHORES BIS-IMIDE POLYCYCLIQUES ET HETEROCYCLIQUES UTILES COMME AGENTS ANTICANCEREUX
申请人:THE DU PONT MERCK PHARMACEUTICAL COMPANY
公开号:WO1995000490A1
公开(公告)日:1995-01-05
(EN) This invention relates to bis-imide derivatives of tri- and tetraamines of formula (I), pharmaceutical compositions containing them, and methods of using them to treat cancer, particularly solid tumors, in mammals.(FR) Cette invention concerne des dérivés bis-imide de triamines et de tétraamines de la formule (I), des compositions pharmaceutiques les contenant et des méthodes d'utilisation de celles-ci pour traiter le cancer, en particulier les tumeurs solides chez les mammifères.